Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_4
4
67%
Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
4(66.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 44 (66.7%)
N/A1 (16.7%)

Trials by Status

completed350%
unknown117%
terminated233%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_4

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

NCT00140049
completedphase_4

12-Month Stability of Diurnal IOP Control on Cosopt

NCT00379834
terminatedphase_3

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT

NCT00767481
completedphase_4

Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT00761995
terminatedphase_4

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

NCT00471068
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00140049Phase 4

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

Completed
NCT00379834Phase 4

12-Month Stability of Diurnal IOP Control on Cosopt

Completed
NCT00767481Phase 3

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT

Terminated
NCT00761995Phase 4

Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension

Completed
NCT00471068Phase 4

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

Terminated
NCT00440336Not Applicable

Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6